Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
APstem Therapeutics logo — An unprecedented era of stem cell therapy has arrived!

APstem Therapeutics

An unprecedented era of stem cell therapy has arrived!

Founded 2017 United States Fremont, United States 7 employees Seed Total: $4.30M Biotechnology, Health Care +1

General Information

Company Name APstem Therapeutics
Founded Year 2017
Location United States Fremont, United States
Employees 7
Industries Biotechnology, Health Care, Life Sciences
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with APstem Therapeutics. To contact APstem Therapeutics, visit apstemtx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does APstem Therapeutics compare?

A PDF of APstem Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting APstem Therapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About APstem Therapeutics

APstem Therapeutics is pioneering an innovative approach in the biotechnology and healthcare sectors with its breakthrough discovery of Adult Pluripotent Stem Cells (APSCs™). Founded in 2017 and based in the United States, the company aims to tackle difficult-to-heal diseases and address aging-related challenges.

Their mission-driven proposition is heralded by the slogan, "An unprecedented era of stem cell therapy has arrived!" This encapsulates their commitment to advancing life sciences through transformative stem cell therapies. In pursuit of this mission, APstem Therapeutics secured a $2.80M Seed Round investment on 01 September 2020 from notable investors such as Beyond Ventures, Oriza Ventures, and Magic Capital.

As a promising player in these high-impact industries, the company presents a compelling opportunity for investors keen on innovative therapeutic solutions targeting unmet medical needs.

Business keywords: Stem cell therapy, Medical breakthrough, Regenerative medicine, Aging research, Healthcare innovation, Disease treatment, APSCs™, Adult pluripotent stem cells, Biomedical technology, Cellular therapy

Services & Products

Development of regenerative cell therapies
Research and innovation in stem cell technology
Manufacturing of off-the-shelf stem cell products

Target Customers

Healthcare providers treating chronic diseases Patients with Type 1 Diabetes Patients with autoimmune and degenerative diseases Biomedical research institutions

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round $2.80M 3
Beyond Ventures Oriza Ventures Magic Capital
Beyond Ventures, Oriza Ventures +1
01 Sep 2020
Seed Round $500.00K 1
Magic Capital
Magic Capital
01 May 2019
Seed Round $1.00M 3
StartX InnoSpring Seed Fund Magic Capital
StartX, InnoSpring Seed Fund +1
01 Aug 2018

APstem Therapeutics Alternatives & Competitors

View All Alternatives
APstem Therapeutics vs
Khloris Biosciences
Khloris Biosciences

Pioneering medical treatment using advanced stem cell technology to address critical cardiovascular...

Venture round
Biotechnology, Life Sciences
Compare APstem Therapeutics vs Khloris Biosciences
APstem Therapeutics vs
Blue Cell Therapeutics
Blue Cell Therapeutics Denmark

We are dedicated to develop novel stem cell therapies to treat chronic diseases

Venture round
15 employees
Biotechnology, Health Care
APstem Therapeutics vs
Institute for Stem Cell Science and Regenerative Medicine (BRIC-inStem)
Institute for Stem Cell Science and Regenerative Medicine (BRIC-inStem) India

Thematic interdisciplinary research that addresses major questions in human biology based on stem ce...

207 employees
Biotechnology, Education
Also compare with: APstem Therapeutics vs Rebirthel Co.,Ltd. Rebirthel Co.,Ltd. View all alternatives

FAQ About APstem Therapeutics

An unprecedented era of stem cell therapy has arrived!
APstem Therapeutics was founded in 2017.
APstem Therapeutics is headquartered in Fremont, United States.
APstem Therapeutics operates in Biotechnology, Health Care and Life Sciences. Its work centres on Stem cell therapy, Medical breakthrough, Regenerative medicine and Aging research. Its customers include Healthcare providers treating chronic diseases, Patients with Type 1 Diabetes and Patients with autoimmune and degenerative diseases.
APstem Therapeutics has approximately 7 employees.
APstem Therapeutics has completed 3 funding rounds, raising a total of $4.30M. The latest funding stage is Seed.
APstem Therapeutics offers: Development of regenerative cell therapies, Research and innovation in stem cell technology, Manufacturing of off-the-shelf stem cell products.
Top alternatives and competitors to APstem Therapeutics include Khloris Biosciences, Blue Cell Therapeutics, Institute for Stem Cell Science and Regenerative Medicine (BRIC-inStem), BlueRock Therapeutics, Garuda Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
APstem Therapeutics and Khloris Biosciences are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for APstem Therapeutics, https://bouncewatch.com/company/apstem-therapeutics, updated 24 October 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes